Join
Live feed
·
INSIDERFilingvia Quantisnow
Rhythm Pharmaceuticals Inc. logo

EVP, Head of North America Lee Jennifer Kayden exercised 56,601 shares at a strike of $17.62 and sold $8,901,531 worth of shares (75,834 units at $117.38) as part of a pre-agreed trading plan, closing all direct ownership in the company (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
RYTM· Rhythm Pharmaceuticals Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track RYTM (Rhythm Pharmaceuticals Inc.) and more on Quantisnow.